Volver a la clasificación

Mettler-Toledo International Inc (MTD)

Sobrevalorada
HealthcareDiagnostics & ResearchSwitzerland

Fundamental

62

Precio

$1486.44

Capitalización Bursátil

$30.96B

Parte 1 · Cuánto vale la empresa

Resumen

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 19 de septiembre de 2026 with claude-haiku-4-5 — shared with all users

P/E: 36.3Score: 68Market cap: $250.91B

Thermo Fisher supplies the same laboratory customers with overlapping lines of analytical instruments, pipettes and process analytics, and competes for the large multi-year supply contracts of pharmaceutical and biotech labs.

P/E: 33.9Score: 72Market cap: $49.40B

Agilent competes for the same analytical-chemistry budget in pharmaceutical and industrial quality-control labs, with chromatography, spectroscopy and lab software that substitute for Mettler-Toledo's analytical instruments.

P/E: 109.6Score: 61Market cap: $43.52B

Waters sells chromatography, mass spectrometry and thermal-analysis systems to the same regulated pharmaceutical and materials laboratories where Mettler-Toledo places its thermal analysis and titration instruments.

P/E: 39.3Score: 65Market cap: $159.81B

Through its life-sciences and diagnostics brands Danaher bids for the same laboratory and bioprocessing equipment, consumables and service contracts, often bundling them across global accounts.

Sartorius AGNot tracked

Sartorius is the closest head-to-head rival in laboratory weighing, selling analytical and precision balances, pipettes and lab consumables to the same pharmaceutical, chemical and academic laboratories.

Shimadzu Corporation (島津製作所)Not tracked

Shimadzu builds balances, moisture analyzers and analytical instruments for the same industrial and laboratory customers, and is the main rival for Mettler-Toledo in Japan and much of Asia.

Balance y Liquidez

Ingresos

$4.13B

Últimos 12 meses (hasta 30/6/2026)

Beneficio Neto

$906M

Últimos 12 meses (hasta 30/6/2026)

Flujo de Caja Libre

$849M

Patrimonio Neto Total

$-24M

Pasivo Total

$3.74B

Ratio de Liquidez

1.12

Cobertura de Intereses

-

Deuda/EBITDA

1.66

Beneficio Por Acción

Ingresos y Beneficio Neto

Flujo de Caja Libre

Desglose de Ingresos

Estado histórico

Márgenes en el tiempo

La deuda en el tiempo

Cuánto pesa la deuda

Cuadro de crecimiento

Crecimiento — Ingresos

Estimación de Valor Justo

Caso generalSobrevalorado

Valor Justo

$1181.36

Precio Actual

$1486.44

Margen de Seguridad

-25.8%

Rango de Valor Justo

$820.70 - $1542.03

Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.

Métodos de Estimación

Precio objetivo de los analistas:$1457.50
Flujo de caja descontado (DCF):$809.83
Múltiplo sobre beneficios (P/E):$1446.10
Fórmula de crecimiento de Graham:$1191.86
Valor de la capacidad de generar beneficios (EPV):$386.72
P/B justificado:$236.18
Descuento de dividendos (Gordon):Datos insuficientes para calcularlo
P/FFO, fondos de operaciones:Datos insuficientes para calcularlo
Beneficios de mitad de ciclo:Datos insuficientes para calcularlo
Múltiplo sobre ingresos:$807.64
Consenso de Analistas:Comprar (10B / 9H / 0S)
Última Sorpresa de Resultados:+5.18%

Métricas de Valoración

Ratio P/E

34.06

ROE

-3677.4%

Ratio P/B

2360.93

P/FCF

35.04

Margen Bruto

60.3%

ROIC

-

Radar de Rentabilidad

Creación de Valor (Ventaja Competitiva)

ROIC

-

WACC

10.6%

ROIC − WACC

-

Criterios de Análisis Fundamental

Superado (17)

  • EPS shows upward trend
  • EPS CAGR 12.37%
  • Price CAGR 11.95%
  • Gross Margin 60.3%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 1816.3%
  • Revenue Growth 5Y 5.5%
  • Analyst Consensus 53% Buy
  • Earnings Surprise avg 3.4%
  • Earnings Quality (OCF/NI) 1.08
  • Share Dilution -3.1%
  • Net Margin Trend 21.9% vs 21.5%
  • Piotroski F-Score 6/9

Fallido (6)

  • P/FCF 35.04
  • P/B Ratio 2360.93
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • PEG Ratio 3.05

No disponible (5)

  • ROIC NaN%
  • Dividend Payout NaN%
  • Debt/Equity ratio
  • Operating Margin NaN%
  • Interest Coverage

Piotroski F-Score

6/9

Señales mixtas: algunas áreas requieren atención

score
criteria

Calidad de los Beneficios

1.08

Alta calidad: beneficios respaldados por efectivo

Dilución de Acciones

-3.1%

Recomprando acciones. Favorable para el accionista

Participaciones institucionales

Gobernanza

Equipo Directivo

NombreCargoEdad
Mr. Patrick K. KaltenbachPresident & CEO62
Mr. Shawn P. VadalaChief Financial Officer56
Ms. Susan Graham-BryceChief Human Resources Officer49
Mr. Marc de La GueronniereHead of European & North American Market Organizations61
Mr. Richard WongHead of Asia/Pacific59
Mr. Markus KoepfliChief Information Officer-
Mr. Adam William UhlmanHead of Investor Relations-
Ms. Michelle M. RoeChief Legal Officer & Corporate Secretary54
Mr. Oliver WittorfHead of Product Inspection, Retail & Global Supply Chain49
Mr. Gerhard KellerHead of Process Analytics56

Riesgo de Auditoría

2

Riesgo del Consejo

1

Riesgo de Compensación

6

Riesgo de Derechos del Accionista

5

Parte 2 · El precio y el momento de entrar

Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.

Documentos

  • Informe anual (10-K)

    Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.

    Presentado el 2026-02-06

    Ver documento
  • Informe trimestral (10-Q)

    Una actualización del desempeño financiero de los últimos tres meses.

    Presentado el 2026-07-31

    Ver documento
  • Informe de hecho relevante (8-K)

    Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.

    Presentado el 2026-08-03

    Ver documento

via SEC EDGAR

Historial de Resultados

via SEC EDGAR

Latest News

Recent headlines for MTD, sourced from Markets Gazette.

No recent news for MTD.